124
Participants
Start Date
February 28, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
January 31, 2010
T89
A two-herb botanical drug product in 62.5mg capsule formulation. It is to be used as 125mg or 187.5mg twice daily.
Marc Kozinn Associates, Williamsville
National Clinical Research-Norfolk, Inc, Norfolk
Three Rivers Medical Associates, Columbia
Cardiovascular Research Center of South Florida, Miami
Sunrise Medical Research, Lauderdale Lakes
Great Lakes Research Group, Inc, Bay City
Gemini Scientific, LLC, Madison
Alexandria Cardiology Clinic, Alexandria
Oklahoma Cardiovascular & Hypertension, Oklahoma City
East Texas Cardiology, Houston
Northwest Houston Cardiology, Houston
Northwest Heart Center, Tomball
Paradigm Clinical, Inc., Tucson
Robert M. Karns, A Medical Corporation, Beverly Hills
Inland Heart Doctors, Corona
Tasly Pharmaceuticals, Inc.
INDUSTRY